Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.
Opinion
United States Court of Appeals for the Federal Circuit ______________________
June 13, 2012
ERRATUM ______________________
Appeal Nos. 2011-1126, -1127
OTSUKA PHARMACEUTICAL CO., LTD.,
Plaintiff-Appellee,
v.
SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., SYNTHON BV, SYNTHON HOLDINGS BV, SYNTHON LABORATORIES, INC., and SYNTHON PHARMACEUTICALS, INC.,
Defendants,
and
APOTEX INC. and APOTEX CORP.,
Defendants-Appellants,
and TEVA PHARMACEUTICALS USA, INC., BARR LABORATORIES, INC., and BARR PHARMACEUTICALS, INC.,
Defendants-Appellants.
Decided: May 7, 2012 Precedential Opinion ______________________
The following change has been made:
Page 21, line 4, “marketed” has been changed to -- promising--.
Free access — add to your briefcase to read the full text and ask questions with AI
Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc. (Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.